银浸渍封闭敷料在全关节置换术后预防感染的成本效益
该研究采用盈亏平衡分析,基于机构数据和文献确定TKA与THA的基线感染率、PJI翻修费用及银浸渍封闭敷料价格,计算其预防PJI所需的最小绝对风险降低。结果显示,在特定感染率和费用条件下,敷料若使TKA感染率降低0.15%、THA降低0.12%即具经济性,且所需绝对风险降低不随初始感染率变化。结论认为银浸渍封闭敷料在全关节置换术后预防感染具有成本效益。
要点
- 银浸渍封闭敷料在TKA感染率降低0.15%(NNT=676)时具成本效益。
- THA感染率降低0.12%(NNT=835)时该敷料具成本效益。
- 所需绝对风险降低不随初始感染率变化,治疗费用低至$10,000时仍<0.40%。
核心结论
- 银浸渍封闭敷料是全膝关节置换和全髋关节置换术后预防感染的成本效益措施。
研究设计与样本
- 基于机构数据和现有文献的盈亏平衡分析,确定TKA与THA基线感染率、PJI翻修费用和敷料价格,计算成本效益所需最小绝对风险降低。
主要发现
- 在感染率1.10%、TKA PJI治疗费用$25,692、THA PJI治疗费用$31,753、敷料价格$38.05的条件下,敷料若使TKA感染率降低0.15%(NNT=676)、THA降低0.12%(NNT=835)则经济可行。
- 所需绝对风险降低不随初始感染率变化,当感染治疗费用低至$10,000时仍小于0.40%(NNT=263),当敷料价格高达$200时仍小于0.80%(NNT=129)。
关键数值与推荐
- TKA感染率降低0.15%(NNT=676)为成本效益阈值。
- THA感染率降低0.12%(NNT=835)为成本效益阈值。
- 感染治疗费用低至$10,000时,所需绝对风险降低<0.40%(NNT=263)。
- 敷料价格高达$200时,所需绝对风险降低<0.80%(NNT=129)。
临床怎么用
- 在TKA和THA术后可考虑使用银浸渍封闭敷料预防PJI,尤其当预期感染率降低幅度达到上述阈值时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prosthetic joint infection (PJI) is a catastrophic complication after total joint arthroplasty that exacts a substantial economic burden on the health-care system. This study used break-even analysis to investigate whether the use of silver-impregnated occlusive dressings is a cost-effective measure for preventing PJI after primary total knee arthroplasty (TKA) and total hip arthroplasty (THA). METHODS: Baseline infection rates after TKA and THA, the cost of revision arthroplasty for PJI, and the cost of a silver-impregnated occlusive dressing were determined based on institutional data and the existing literature. A break-even analysis was then conducted to calculate the minimal absolute risk reduction needed for cost-effectiveness. RESULTS: The use of silver-impregnated occlusive dressings would be economically viable at an infection rate of 1.10%, treatment costs of $25,692 for TKA PJI, and $31,753 for THA PJI and our institutional dressing price of $38.05 if it reduces infection rates after TKA by 0.15% (the number needed to treat [NNT] = 676) and THA by 0.12% (NNT = 835). The absolute risk reduction needed to maintain cost-effectiveness did not change with varying initial infection rates and remained less than 0.40% (NNT = 263) for infection treatment costs as low as $10,000 and less than 0.80% (NNT = 129) for dressing prices as high as $200. CONCLUSION: The use of silver-impregnated occlusive dressings is a cost-effective measure for infection prophylaxis after TKA and THA.
引用
- Toppo AJ, Pagani NR, Moverman MA, et al. The Cost-Effectiveness of Silver-Impregnated Occlusive Dressings for Infection Prevention After Total Joint Arthroplasty. J Arthroplasty. 2020. PMID: 33281021. doi:10.1016/j.arth.2020.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。